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Abstract
The present study aimed to identify biologically active secondary metabolites from
the rare plant species, Pulsatilla patens subsp. patens and the cultivated P. vulgaris
subsp. vulgaris. Chromatographic fractionation of the ethanolic extract of the roots
of P. patens subsp. patens resulted in the isolation of two oleanane-type glycosides
identified as hederagenin 3-O-β-d-glucopyranoside (2.7 mg) and hederagenin
3-O-β-d-galactopyranosyl-(1→2)-β-d-glucopyranoside (3.3 mg, patensin). HPLC
analysis of the methanolic extract of the crude root of P. patens subsp. patens and P.
vulgaris subsp. vulgaris revealed the presence of Pulsatilla saponin D (hederagenin
3-O-α-l-rhamnopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-l-arabinopyranoside).
Chromatographic analysis using GC-MS of the silylated methanolic extracts from
the leaves and roots of these species identified the presence of carboxylic acids,
such as benzoic, caffeic, malic, and succinic acids. The extracts from Pulsatilla species were tested for their antifungal, antimicrobial, and antimalarial activities, and
cytotoxicity to mammalian cell lines. Both P. patens subsp. patens and P. vulgaris
subsp. vulgaris were active against the fungus Candida glabrata with the half-maximal
inhibitory concentration (IC50) values of 9.37 µg/mL and 11 µg/mL, respectively.
The IC50 values for cytotoxicity evaluation were in the range of 32–38 μg/mL for P.
patens subsp. patens and 35–57 μg/mL for P. vulgaris subsp. vulgaris for each cell
line, indicating general cytotoxic activity throughout the panel of evaluated cancer
and noncancer cells.
Keywords
pasque flower subspecies; oleanane-type triterpenoid glycosides; carboxylic acids;
antifungal and antimicrobial activities; cytotoxicity; medicinal applications

Introduction
Plants are known to produce different biologically active substances, including secondary metabolites. It had been reported that plants from the Pulsatilla genus contain
ranunculin, anemonin, protoanemonin, triterpenes, and saponins (9%) of mainly the
oleanane and lupane-type [1,2]. These metabolites were also subjected to analyses in order
to determine the contents of polyphenol compounds, flavonoids, and anthocyanidins
Published by Polish Botanical Society
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[3,4]. The triterpene saponins were isolated from P. chinensis (Bunge) Regel [5], P.
koreana Nakai [6], P. cernua (Thunb.) Bercht. et Opiz. [7], P. dahurica (Fisch. ex DC.)
Spreng. [8], P. turczaninovii Kryl. et Serg. [9], P. nigricans Storck [10], P. pratensis (L.)
Mill. [11], and P. patens subsp. multifida (G. A. Pritzel) Zämelis [12]. Polyphenolic
compounds such as flavonoids and anthocyanidins are produced by P. montana subsp.
balcana (Velen.) Zämelis & Paegle, P. halleri subsp. rhodopaea (Stoj. et Stef.) K. Krause,
and P. slaviankae (Zimmer.) Jordanov & Kožuharov [13]. The saponins produced by
Pulsatilla species show high biological activity across a wide range as an anticancer [14],
neuroactive [15], neuroprotective [16], immunomodulating [17], cognitive function
enhancing [18], antioxidant [19], antimicrobial [20], and cytotoxic agents [21].
Pulsatilla species are rarely of toxicological importance, as while they are moderately
hazardous, they are mutagenic and contain cellular poison [22]. The active ingredient
in fresh plant material, a terpenoid glucoside known as ranunculin, is broken down
to protoanemonin [23]. Protoanemonin is a reactive compound with an exocyclic
methylene group and is mutagenic, because it can bind to the SH-group of proteins and
DNA. Protoanemonin is an irritant lactone
that causes allergic dermatitis in human
skin [24], and internally, paralysis of the
central nervous system and gastrointestinal
disturbance [25]. When the plant is dried,
the protoanemonin dimerises to form the
less toxic anemonin, if it has not already
alkylated proteins [23].
Despite the potential toxicity of Pulsatilla
species, their natural products have been
used for centuries in traditional Chinese
and Korean medicine for the treatment of
many diseases and ailments. They are known
as herbal drugs used for the homeopathic
treatment of eye ailments, earache, stress,
anxiety, tension, skin eruptions, rheumatism, headaches, neuralgia, insomnia, hyperactivity, bacterial skin infections, septicemia,
bronchitis, coughs, and asthma [26].
The Pulsatilla genus is composed of 38
species in the Northern Hemisphere [23].
The species of Pulsatilla patens subsp. patens
and P. vulgaris subsp. vulgaris have not been
extensively studied. The existing research
focuses primarily on genetic characteristics
of the species [27], ecology [28], and various aspects of developmental biology [29].
Pulsatilla patens subsp. patens is a lowland
species of Boreo-meridional-continental
distribution [30] and is native to Europe,
Russia, Mongolia, China, Canada, and the
United States [31] (Fig. 1A).
Pulsatilla patens subsp. patens is an endangered plant and is considered critically
threatened in the Czech Republic [32], included in the red data books of Germany
as an endangered plant [33], vulnerable in
Sweden [34], relatively restored in Lithuania,
and in decreasing number in the St. Petersburg and Kaliningrad [35] regions of Russia,
Latvia [36], and Slovakia [37]. In Finland
and Estonia, the populations of P. patens
subsp. patens are considered to be relics [38].
Fig. 1 Distribution of Pulsatilla patens subsp. patens (A) in Europe, Asia, and
In Poland, P. patens subsp. patens has been
North America [31], and (B) in Poland [40].
strictly protected since 1958 and requires
© The Author(s) 2019
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active protection [39]. On the territory of
Poland, P. patens subsp. patens reaches the
western border of its range and the number
of its sites clearly decreases towards the west
and south [40] (Fig. 1B).
Pulsatilla vulgaris subsp. vulgaris is a species occurring across Central Europe, ranging from France in the south to Sweden at
its northern limit [31] (Fig. 2A) and is listed
as “near threatened“ by the International
Union for Conservation of Nature [41]. Currently, P. vulgaris subsp. vulgaris is listed
as vulnerable (VU category) in Ukraine,
Slovakia [42], Sweden [43], and the United
Kingdom [44]. This species is also classified
as endangered (EN category) in Germany
[45] and Switzerland [46] and as critically
endangered (CR category) in Austria [47].
In Poland, it is listed as an extinct (RE category) species [48] and mainly cultivated.
Pulsatilla vulgaris subsp. vulgaris is currently
extinct in Poland on natural sites [49]. It was
only reported at four sites before 1930 [40]
(Fig. 2B) on the habitats of the pine forests
of the All. Dicrano-Pinion.
The aim of this study was the identification of biologically active secondary metabolites from the rare plant species Pulsatilla
patens subsp. patens and the cultivated P.
vulgaris subsp. vulgaris. In the course of our
study, we evaluated the extracts of leaves
and roots of these plant species for their
antifungal, antimicrobial, and antimalarial
activities, and cytotoxicity to mammalian
cell lines.

Material and methods
Material collection
Fig. 2 Distribution of Pulsatilla vulgaris subsp. vulgaris (A) in Central Europe
[31] and (B) in Poland [40].

The leaves and roots of P. patens subsp. patens were collected in May 2013–2015 at the
Knyszynska Forest near Bialystok City, NE
Poland, while P. vulgaris subsp. vulgaris were obtained from cultivation at the Herbarium
“The Herbal Corner” in May 2015, Podlaskie Province, NE Poland. Plant material was
identified by Prof. Grażyna Łaska from the Bialystok University of Technology, Faculty
of Civil and Environmental Engineering, Poland.
Extraction and chromatographical analysis
TLC/CC analysis. For thin layer chromatography (TLC) and column chromatography
(CC), ethanolic extracts were prepared from roots of P. patens subsp. patens (K2). Dried
roots of P. patens subsp. patens (10 g) were extracted with 1 L of 50% aqueous EtOH at
room temperature for 12 h and then filtered. The extraction was repeated three times.
The combined filtrates were concentrated in a vacuum evaporator to obtain a syrupy
brown residue (0.95 g). Then 5 mg of ethanolic extract from roots of P. patens subsp.
patens (K2) was transferred to normal and reverse phase (RP) TLC on silica gel with

© The Author(s) 2019
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fluorescence (stationary phase). The following solvent system was used for normal
phase TLC: hexanes–ethyl acetate (C6–H14–C4H8O2; 60:40), chloroform–methanol
(CHCl3–MeOH; 90:10) (Fig. 3) and for reverse phase TLC: water–methanol (H2O–
MeOH; 30:70), water–methanol (H2O–MeOH; 70:30). The solvent system H2O–MeOH
(30:70) was found to be best for RP-TLC. A solution of H2SO4–MeOH (5:95) and UV
254 and 366 nm were used as a detecting reagent (Fig. 3). In the next step, an ethanolic
extract of the roots of P. patens subsp. patens was fractionated by CC (0.9 g) using
CHCl3–MeOH gradient (90:10). Compounds were eluted by reverse-phase C18 column
using the H2O–MeOH (30:70) solvent system (Fig. 4). The structures of the isolated
compounds were determined by 1H and 13C-NMR spectroscopy.

Fig. 3 TLC image of the ethanolic extract of roots (K2) of Pulsatilla patens subsp.
patens and identification of Compound 1 and 2.

Fig. 4 Column chromatography of the ethanolic extract of Pulsatilla patens
subsp. patens roots and isolation of Compound 1 and 2.

HPLC analysis. The fraction which exhibited the most potent activity was again
chromatographed by high performance liquid chromatography (HPLC) using Agilent
Technologies 1260 Infinity system. The HPLC profiles were determined at 35°C on a
COSMOSIL Packed Column 5C-18-MS-II (4.6 μm × 250 mm) (Nacalai, USA) eluted
with methanol (A) and water (B) as mobile phases in a linear gradient elution with the
flow rate of 1 mL/min. The elution program was as follows: 0–8 min, 90% A to 77%
© The Author(s) 2019
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A, 8–25 min, changed to 71% A, 25–40 min, to 60% A, 40–50 min, to 50% A, 50–75
min, to 10% A, 75–80 min, to 0% A [50]. The volume of sample injected was 35 µL.
Fluorescence was monitored by an Agilent 1260 Infinity Fluorescence Light Detector
(Agilent Technologies, USA; 210 nm excitation and 460 nm emission wavelength). The
analytical data were integrated using the Agilent OpenLAB software. The fraction was
purified by HPLC to give Pulsatilla saponin D. The peak of Pulsatilla saponin D was
identified based on retention time with respect to the reference standard (purchased
from Toronto Research Chemicals) previously run in an analytical HPLC.
GC-MS analysis. The pressurized solvent extractions were performed using a Büchi
E-916 Speed Extractor. The raw materials were extracted with methanol (leaves 32.3 g,
and roots, 23.6 g of P. patens subsp. patens; leaves, 21.8 g and roots, 56.1 g of P. vulgaris
subsp. vulgaris). The extraction time was 30 min, temperature 100°C and pressure 1.2
× 107 Pa. Three extracts were prepared from each raw material. Extracts were filtered
through paper filters. The methanol was dried using a rotor evaporator.
Each dry residue (10 mg) was redissolved with 1 mL of pyridine and 200 µL BSTFA
[Ν,Ο-bis-(trimethylsilyl)-trifluoroacetamide] added. Next, the mixture was heated at
60°C for 30 min. The solution was analyzed by gas chromatography / mass spectrometry
(GC-MS) using an Agilent 7890A gas chromatograph equipped with an Agilent 5975C
mass selective detector. The injection of a 1-µL sample was performed using an Agilent
7693A autosampler. The separation was performed on an HP-5MS (30 m × 0.25 mm
× 0.25 μm film thickness) fused silica column at a helium flow rate of 1 mL/min. The
injector worked in split mode (1:5), and the injector temperature was 280°C. The initial
column temperature was 50°C, rising to 310°C at 3°C/min and the final temperature was
held for 10 min. The ion source and quadrupole temperatures were 230°C and 150°C,
respectively. The ionization energy (EIMS) was 70 eV. The detection was performed in
full scan mode from 41 to 600 amu.
After integration, the percentage of each component in the total ion current (TIC)
was calculated. Mass spectral data and calculated retention indices were used to
identify the compounds. The mass spectrometric identification was carried out with
an automated system of GC-MS data processing supplied by the National Institute of
Standards and Technology (NIST). Retention indices of the analytes were determined,
taking into account C10–C40n-alkanes retention times and comparing them with the
NIST database.
Antimicrobial assay
For the antimicrobial assay, we used the fungi Candida albicans ATCC 90028, C.
glabrata ATCC 90030, C. krusei ATCC 6258, Cryptococcus neoformans ATCC 90113,
and Aspergillus fumigatus ATCC 204305 and the bacteria Staphylococcus aureus ATCC
29213, methicillin-resistant S. aureus ATCC 33591 (MRS), Escherichia coli ATCC 35218,
Pseudomonas aeruginosa ATCC 27853, and Mycobacterium intracellulare ATCC 23068
from the American Type Culture Collection (Manassas, VA). The testing was performed
using a modified version of the CLSI method (formerly NCCLS) [51–54] except for M.
intracellulare, where a modified method by Franzblau et al. [55] was used. All samples
were diluted in 20% DMSO/saline and then transferred in duplicate to microplates. In
order to obtain final target inocula, microbial inocula were prepared by correcting the
optical density at 630 nm (OD630) of the microbe suspensions in the incubation broth.
In each assay, drug controls were used, with ciprofloxacin (ICN Biomedicals, USA) for
the bacteria and amphotericin B (ICN Biomedicals, Ohio) for the fungi. The readings
were made for all organisms before and after incubation at either 530 nm using the
Biotek Powerwave XS plate reader (Bio-Tek Instruments, USA) or 544 excitation / 590
emission, (M. intracellulare, A. fumigatus) using the Polarstar Galaxy Plate Reader (BMG
LabTechnologies, Germany). To determine the minimum fungicidal or bactericidal
concentrations required, 5 µL was removed from each clear well, transferred to agar,
and incubated. The MFC/MBC (the lowest test concentration that kills the organism)
was also established.

© The Author(s) 2019
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Antimalarial assay
In the antimalarial assay, the chloroquine sensitive (D6) strain of Plasmodium falciparum
was used and plasmodial LDH activity was measured using the procedure devised by
Makler and Hinrichs [56]. To the wells of a 96-well plate containing 10 µL of diluted
sample, a suspension of red blood cells infected with P. falciparum of 200 µL was
introduced, together with 2% parasitemia and 2% hematocrit in RPMI 1640 medium
supplemented with 10% human serum and 60 µg/mL Amikacin. Then, the plate was
incubated at 37°C for 72 h with 90% N2, 5% O2, and 5% CO2 using a modular incubation chamber. In order to determine the parasitic LDH activity, 20 µL of the incubation
mixture was mixed with 100 µL of the Malstat reagent (Flow Inc., USA) and incubated
at room temperature for 30 min. Then, 20 µL of a 1:1 mixture of NBT/PES (Sigma,
USA) were added and the plate was incubated in the dark for 1 h. To stop the reaction,
100 µL of a 5% acetic acid solution was added and the absorbance was read at 650 nm.
The drug controls were artemisinin and chloroquine. The half-maximal inhibitory
concentration (IC50) values were calculated on the basis of the dose response curves of
growth inhibition using XLfit 4.2 (IDBS, USA).
Cytotoxicity assay
In the cytotoxicity assay, the root extract was tested against a panel of cancer and noncancer cell lines. In this assay, we used 96-well tissue culture-treated plates. The cells were
seeded at a density of 25,000 cells/well and grown for 24 h. Next, samples of the extract
at different concentrations were added and cells were incubated for 48 h. The neutral
red method [57] was used to determine the cell viability. The IC50 values were obtained
on the basis of dose response curves. Doxorubicin was used as the control drug.

Results
Chromatographic fractionation of the ethanolic extract (0.9 g) of the roots of P. patens
subsp. patens resulted in the isolation of two oleanane-type glycosides identified as hederagenin 3-O-β-d-glucopyranoside (2.7 mg) and hederagenin 3-O-β-d-galactopyranosyl(1→2)-β-d-glucopyranoside (3.3 mg, patensin) (Fig. 5).

Compound 1

Compound 2

Hederagenin 3-O-β-D-glucopyranoside

Hederagenin 3-O-β-D-galactopyranosyl-(1→2)-βD-glucopyranoside

Fig. 5 Structures of two oleanane-type glycosides isolated from Pulsatilla patens subsp. patens.

© The Author(s) 2019
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HPLC analysis of the silylated methanolic extract of the crude root of P. patens
subsp. patens and P. vulgaris subsp. vulgaris revealed the presence of Pulsatilla saponin
D – hederagenin 3-O-α-l-rhamnopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-larabinopyranoside (Fig. 6). Analysis of the chromatographic spectra of the extracts
from P. patens subsp. patens and P. vulgaris subsp. vulgaris showed similar spectra to the
standard solution chromatogram of Pulsatilla saponin D. The other chromatographic
peaks for the extracts of P. patens subsp. patens and P. vulgaris subsp. vulgaris also showed
the presence of triterpenoid saponins, which will need to be investigated further. The
Pulsatilla saponin D has not been isolated in Pulsatilla medicinal plants in Poland until
now, with this type of study being conducted here for the first time. Pulsatilla saponin
D, C47H76O17, has multiple demonstrated biological properties including antifungal,
antimicrobial, and cytotoxic activities.
A
1

B

C
1

1

D
1

Hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl(1→4)]-α-Larabinopyranoside
Pulsatilla saponin D. Synonyms: 3β-[(O-β-D-glucopyranosyl-(1→4)-O-[α-L-rhamnopyranosyl-(1→2)]-α-Larabinopyranosyl)oxy]-23-hydroxyolean-12-en-28-oic acid; hederacolchiside A; hederagenin 3-O-[β-Dglucopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]]-α-larabinopyranoside; hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-[β-D-glucopyranosyl-(1→4)]-α-larabinopyranoside; SB 365.

Fig. 6 HPLC chromatogram of standards Pulsatilla saponin D – 1 (A); HPLC spectrum of the triterpenoid saponins
(Pulsatilla saponin D – 1) in Pulsatilla patens subsp. patens (B); HPLC spectrum of the triterpenoid saponins (Pulsatilla
saponin D – 1) in Pulsatilla vulgaris subsp. vulgaris (C) and the structure of Pulsatilla saponin D (1) isolated from Pulsatilla
patens subsp. patens and Pulsatilla vulgaris subsp. vulgaris (D).
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Carbohydrates were the main components of the extracts from P. patens subsp.
patens and P. vulgaris subsp. vulgaris. The content of carbohydrates in each extract
from P. patens subsp. patens was over 60% while those from P. vulgaris subsp. vulgaris
were over 90% carbohydrates. The analyzed extracts that were the most abundant were
saccharose, glucopyranose and fructofuranose. The extracts from the leaves of these
species revealed the presence of carboxylic acids, such as benzoic, caffeic, malic, and
succinic acids. Furthermore, glyceric, quinic, and protocatechuic acids were identified
in the leaf extracts of P. patens subsp. patens, while the roots extracts from P. vulgaris
subsp. vulgaris contained the smallest amount of carboxylic acids (Tab. 1).
Microbiological assays of the root extracts showed activity against the fungal
pathogen Candida glabrata, indicated by the IC50 value of 9.37 μg/mL for P. patens
subsp. patens and 11 µg/mL for P. vulgaris subsp. vulgaris (Tab. 2, Tab. 3). This result is
particularly important as with the increasing use of immunosuppressants, the number
of cases of inflammation of mucous membranes and particular systems by C. glabrata
have significantly increased, especially in people with human immunodeficiency virus.
Candida glabrata has become the second most important agent responsible for surface
(oral cavity, esophagus, vaginal, or urinary duct) or systemic inflammation. The main
problem with the inflammation caused by C. glabrata is their innate resistance to azole
antibiotics that are very effective against other Candida species. Treatment of C. glabratacaused inflammation often require the use of amphotericin B that is toxic for humans
and can trigger undesired side effects [58]. It has been experimentally shown that the
root extracts form Pulsatilla species can contribute to new, safer drugs in antifungal
therapy against C. glabrata.
Tab. 1 Relative chemical composition (% of TIC) of Pulsatilla patens subsp. patens and P. vulgaris subsp. vulgaris extracts.

Group of compounds

tret. (min)

Carbohydrates
such as:

Fresh leaves
of P. patens

Fresh roots
of P. patens

69.77 ±3.49

88.17 ±4.41

2.12 ±0.11

3.37 ±0.17

42,998

tret. (min)

Fresh leaves
of P. vulgaris

Fresh roots
of P. vulgaris

94.14 ±4.71

96.46 ±4.82

4.28 ±0.21

1.02 ±0.05

α-Fructofuranose

32,494

β-Fructofuranose

42,678

2.53 ±0.13

7.68 ±0.38

43,286

4.39 ±0.22

4.19 ±0.21

α-D-Glucopyranose

45,290

13.44 ±0.67

10.19 ±0.51

45,928

16.80 ±0.84

16.89 ±0.84

β-D-Glucopyranose

48,449

17.44 ±0.87

9.42 ±0.47

49,055

19.53 ±0.98

16.81 ±0.84

Saccharose

66,784

14.98 ±0.75

25.74 ±1.29

67,461

23.52 ±1.18

53.65 ±2.28

21.83 ±1.09

3.33 ±0.17

1.13 ±0.06

0.07 ±0.01

Carboxylic acids
such as:
Laevulic acid

-

-

-

15,035

0.05 ±0.01

-

Benzoic acid

19,169

0.03 ±0.01

0.06 ±0.01

19,765

0.04 ±0.01

-

4-Hydroxyvaleric acid

20,763

0.16 ±0.01

-

Succinic acid

22,526

-

0.34 ±0.02

0.17 ±0.01

23,108

0.07 ±0.01

-

Malic acid

30,260

1.04 ±0.05

1.62 ±0.08

30,861

0.73 ±0.04

0.07 ±0.01

2-Hydroxyglutaric acid

-

-

-

-

-

32,448

0.04 ±0.01

-

(E)-Ferulic acid

50,432

0.01 ±0.01

0.02 ±0.01

-

-

-

(E)-Caffeic acid

51,967

1.49 ±0.08

-

52,588

0.06 ±0.01

-

Glyceric acid

23,728

8.46 ±0.42

0.05 ±0.01

-

-

-

3-Phenyllactic acid

33,465

-

0.28 ±0.01

-

-

-

Protocatechuic acid

41,965

2.12 ±0.11

-

-

-

Shikimic acid

42,394

-

0.22 ±0.01

-

-

-

Quinic acid

44,256

7.58 ±0.38

0.58 ±0.03

-

-

-

-

Amino acids

2.24 ±0.11

0.58 ±0.03

-

-

Other compounds

5.90 ±0.30

3.86 ±0.19

0.57 ±0.03

1.39 ±0.07

Unidentified compounds

0.17 ±0.01

4.06 ±0.20

4.16 ±0.21

2.08 ±0.10
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Tab. 2 The test results of the antimicrobial activity of leaf and root extracts of Pulsatilla patens subsp. patens and Pulsatilla vulgaris
subsp. vulgaris (primary screen).

Tested strain
C. albicans

Extracts from
leaves of P. p.
(50 µg/mL)

Extracts from
roots of P. p.
(50 µg/mL)

Extracts from
leaves of P. v.
(50 µg/mL)

Extracts from
roots of P. v.
(50 µg/mL)

Amphotericin
B (5 µg/mL)

Ciprofloxacin
(1 µg/mL)

2*

27

11

24

100

ND

C. glabrata

0

100

14

98

100

ND

C. krusei

0

17

15

16

100

ND

A. fumigatus

7

3

21

11

99

ND

C. neoformans

0

22

0

40

82

ND

S. aureus

0

8

7

16

ND

89

MRSA

0

10

9

9

ND

94

E. coli

5

11

20

24

ND

96

P. aeruginosa

4

4

7

11

ND

100

M. intracellulare

0

0

0

0

ND

72

* The results in %. ND – not determined; P. p. – Pulsatilla patens; P. v. – Pulsatilla vulgaris.

Tab. 3 Dose response (IC50 in µg/mL) results of the roots extracts of Pulsatilla patens subsp. patens and P.
vulgaris subsp. vulgaris.
Extracts from
roots of P. patens

Extracts from
roots of P. vulgaris

Amphotericin B

Ciprofloxacin

C. albicans

NA

NA

0.19

ND

C. glabrata

9.37*

11

0.37

ND

C. krusei

NA

NA

0.67

ND

A. fumigatus

NA

NA

1.17

ND

42.27

NA

0.18

ND

Test strain

C. neoformans
S. aureus

NA

NA

ND

0.09

MRS

NA

NA

ND

0.08

E. coli

NA

NA

ND

0.01

P. aeruginosa

NA

NA

ND

0.07

M. intracellulare

NA

NA

ND

0.37

* The results in IC50. ND – not determined; NA – not active at 200 µg/mL

The extracts from the leaves and roots of this plant species showed lower ability to
inhibit the growth of the four different fungi (Candida albicans, C. krusei, Aspergillus
fumigatus, and Cryptococcus neoformans) and other bacteria (Staphylococcus aureus,
MRSA, Escherichia coli, and Pseudomonas aeruginosa) pathogenic to humans (Tab. 2,
Tab. 3). As far as C. albicans, A. fumigatus, E. coli, and P. aeruginosa are concerned,
the leaf and root extracts have been found to show biological activity. Although their
activity is rather low, the extracts are still highly valuable as C. albicans is a frequent
fungus pathogen in humans. This species is responsible for the painful inflammation
of mucous membranes, e.g., vagina inflammation in women or oral-pharyngeal thrush
in AIDS patients. In certain groups of sensitive patients, this species is responsible for
serious and life threatening bloodstream inflammation and subsequent inflammation
of internal organs [59]. The extracts from Pulsatilla species are also attractive in fighting
A. fumigatus, which is one of the most common saprophytic fungi in the air. With an
increasing number of patients treated with immunosuppressants, the incidence of serious and usually lethal invasive aspergillosis has also considerably increased worldwide
[60]. Extracts from Pulsatilla species are also promising agents for the treatment of E.
coli caused inflammation. This bacteria strain is the dominant facultative anaerobic
© The Author(s) 2019
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component of the flora of the human large intestine. It
can cause inflammation of the urinary tract, sepsis, meningitis, intestinal diseases, and diarrhea, and is difficult
to treat as it is resistant to antimicrobial agents [61]. The
Plasmodium falciparum
Pulsatilla extracts should also be considered in fighting
(D6 % inhibition)
P. aeruginosa, the opportunistic pathogen responsible for
hospital infections in patients with immunodeficiency.
97
This pathogen causes inflammation of the lungs related to
94
the use of a respirator, inflammation of the urinary tract,
98
wounds in patients with serious burns, as well as sepsis
0
[62]. Unfortunately, the extracts considered are inactive
against M. intracellulare.
27
In our antimalarial assays, the extracts from the leaves
8
and roots showed low activity against the protozoan (27% of
1
inhibition for P. patens subsp. patens and 1–8% for P. vulgaris
subsp. vulgaris), while the antimalarial drug chloroquine
(positive control) showed 94–98% inhibition (Tab. 4).
The root extracts showed cytotoxicity to all the cell lines included in the assay. As
shown in Tab. 5, the IC50 for cytotoxicity of P. patens subsp. patens was in the range of
32–38 μg/mL and for P. vulgaris subsp. vulgaris, 35–57 µg/mL for each cell line, indicating general cytotoxic activity throughout the panel of cancer and noncancer cells.

Tab. 4 The test results of the antimalarial activity of leaf and
root extracts of Pulsatilla patens subsp. patens and P. vulgaris
subsp. vulgaris.

Tested strain
Chloroquine
Chloroquine
Chloroquine
Extracts from leaves of P. patens
Extracts from roots of P. patens
Extracts from leaves of P. vulgaris
Extracts from roots of P. vulgaris

Tab. 5 Cytotoxicity of Pulsatilla patens subsp. patens and P. vulgaris subsp. vulgaris roots extracts
towards a panel of mammalian cell lines.
IC50 µg/mL
SK-MEL

KB

BT-549

SK-OV-3

LLC-PK1

Vero

Root extract of
P. patens

34.0

38.0

32.0

32.0

36.0

32.0

Root extract of
P. vulgaris

44.0

42.0

57.0

35.0

42.0

39.0

Doxorubicin*

1.7

1.7

2.2

2.3

1.6

>5.0

Sample name

Cell lines: SK-MEL – skin melanoma; KB – epidermal carcinoma; BT-549 – breast cancer; SK-OV-3 –
ovarian cancer; LLC-PK1 – kidney epithelial; Vero – kidney fibroblast. * Positive control drug.

Discussion
The extract of the roots of P. patens subsp. patens revealed the presence of two oleananetype glycosides identified as hederagenin 3-O-β-d-glucopyranoside and hederagenin
3-O-β-d-galactopyranosyl-(1→2)-β-d-glucopyranoside (patensin). Structures of both
compounds were established via comparing 1H and 13C-NMR spectral data on compounds
reported earlier by other authors [63,64]. Patensin, C42H68O14, a triterpenoid glycoside,
was also isolated from the ethanolic extract of roots of P. patens subsp. multifida [63]
and five oleanane-type glycosides and two triterpene saponins were also isolated from
the roots of P. patens subsp. multifida [64]. Phytochemical studies of new secondary
metabolites from P. patens subsp. multifida have revealed the presence of a hitherto
unknown saponin [12]. This saponin isolated from the methanolic extract of this
plant has been found to inhibit the growth of skin cancer. Roots from P. patens subsp.
multifida have been used historically in traditional Chinese medicine [26] as the agent
shows anticancer, antimalarial, and antibacterial properties. At present, it is used as a
homeopathic drug for the treatment of the ear conditions, exanthema, rheumatism,
bronchitis, coughing, asthma, as well as an agent for alleviating stress and anxiety.
The triterpene acid and triterpene glycosides (saponins Pulsatilla A and B) were
isolated from the plant material of P. chinensis [65]. The triterpene acid shows high
cytotoxic activity against the malignant cells of lung cancer. The triterpene saponins are
used for the treatment of inflammatory conditions [66] and reveal high antiprotozoal
© The Author(s) 2019
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[67], antibacterial [68], antiparasitic [69], antifungal [70], and molluscicidic [71] activities. These saponins have also been used for the treatment of indigestion, premenstrual
tension syndrome, and psychosomatic disturbances [72].
Six new saponins, five lupanes, and one oleanane [hederagenin 3-O-β-dglucopyranosyl-(1→4)-β-d-glucopyranosyl-(1→3)-α-l-rhamnopyranosyl-(1→2)-α-larabinopyranoside], along with 11 known saponins, were also isolated from the roots of
P. koreana [2]. The extracts from P. koreana were also determined to contain ranunculin,
anemonin, protoanemonins, triterpenes, and saponins (9%). As evidenced in studies on
the pharmacological use of components isolated from the extract, its protoanemonins
show antifungal properties and antibiotic activity. Moreover, the biologically active compounds isolated from the root extract of P. koreana have been found to show anticancer
[73], anti-inflammatory [74], antiparasitic [75], and antibacterial [76] activities.
HPLC analysis of the root extract of P. patens subsp. patens and P. vulgaris subsp.
vulgaris revealed the presence of Pulsatilla saponin D – hederagenin 3-O-α-l-rhamnopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-l-arabinopyranoside. Results of
numerous phytochemical studies have confirmed high content of triterpenoid saponins
of lupane or oleanane-type in the extract of the root of P. koreana and P. chinensis [2,77]
and their chromatographic spectra [50] are similar to those obtained for P. patens subsp.
patens and P. vulgaris subsp. vulgaris (Fig. 7A). All structures of triterpenoid saponins
(pulsatilloside, Pulsatilla saponin, anemoside, hederacolchiside, and cussosaponin)
isolated from P. koreana roots were elucidated by comparative analysis of spectral
data [78].
Analysis of HPLC fingerprints of different species of Pulsatilla (P. koreana, P. chinensis,
P. ambigua, P. dahurica, P. turczaninovii) showed significant differences between their
HPLC fingerprints, but with 10 common peaks (Fig. 7B). These common peaks not only
can be used to classify and authenticate Pulsatilla species, but also provide important

A

B

Fig. 7 HPLC-ELSD chromatogram of mixed standards and 15 samples extract of Pulsatilla koreana
Nakai with spectrum of the triterpenoid saponins (pulsatilloside E, Pulsatilla saponin H, anemoside
B4, hederacolchiside E, and cussosaponin C-5) (A) [78], and 10 common peaks of different Pulsatilla
species on HPLC fingerprint study (B) [50].
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references for HPLC fingerprints and quality control of Pulsatilla medicinal plants [50].
These studies confirmed chromatographic spectra can show differences depending
on the Pulsatilla species. Significant differences between P. koreana and P. dahurica,
and between P. turczaninovii and P. ambigua were observed. Slight differences in the
chromatographic spectra were also found for P. patens subsp. patens and P. vulgaris
subsp. vulgaris; however, the presence of the triterpenoid saponins and the biological
activity of their plant extracts were demonstrated for the first time in this work. This
is very important because the triterpenoid saponins, such as Pulsatilla saponin D
(C47H76O17), have demonstrated multiple biological properties including antifungal,
antimicrobial, and cytotoxic activities. These compounds are also produced from the
root of several Pulsatilla species, including P. koreana [1], P. chinensis [79], and P. cernua
[80]. In particular, Pulsatilla saponin D shows high cytotoxic activity against cancer
cells. Pulsatilla saponin D isolated from the root of P. koreana showed potent inhibition
rate of tumor growth (IR, 82%) at the dose of 6.4 mg/kg on BDF1 mice bearing Lewis
lung carcinoma (LLC) cells [1]. This compound is also proving to be promising for the
treatment of Alzheimer’s disease [15].
It has been reported that the extracts from other species containing triterpenoid
saponins, with hederagenin being the active ingredient, showed marked inhibition
of serotonin (5-HT), norepinephrine (NE), and dopamine (DA) transporters [81].
Monoamine transporter inhibition studies on pure isolated compounds have not been
reported yet, hence the importance of performing CNS studies on isolated compounds
from Pulsatilla species. In future, we will focus on pure isolated compounds from P.
patens subsp. patens and P. vulgaris subsp. vulgaris and submit them to the Psychoactive
Drug Screening Program (PDSP), Chapel Hill, NC for monoamine transporter inhibition studies for extracellular monoamines including serotonin (5-HT), norepinephrine
(NE), and dopamine (DA) transporters. The two oleanane-type glycosides have been
sent to the National Center for the Natural Product Research (NCNPR) at the University
of Mississippi to evaluate their antimicrobial activity.
Currently, this preparation, which is called SB31, is undergoing phase II clinical
studies in Korea. It was previously reported that SB31 exhibited cytotoxic activity
against some human cancer cell lines and potent antitumor activity on a mouse tumor
model. An active antitumor constituent from the roots of P. koreana was isolated and
the main component was found to be deoxypodophyllotoxin (DPT), which exhibited
antiangiogenic activity and good antitumor activity against mice bearing LLC cells.
However, the DPT content of Pulsatillae Radix, which is an active constituent of SB31,
is too low for discernible antitumor activity. This suggests that DPT is not the major
constituent responsible for the antitumor activity of P. koreana roots.
The extracts from P. cernua have been found to contain anthocyanidins, as well as
triterpene saponins and phytosterols [82]. The natural dyes isolated from P. cernua show
antiallergic, antifungal, anticancer, and antiulcer activity. Moreover, they improve blood
flow in coronary arteries and reduce blood pressure so are attractive substances for the
treatment of atherosclerosis. The anthocyanidins isolated from the extracts have been
used in medicine as perspiration-promoting agents in the treatment of colds and in
the treatment of inflammation of the stomach and intestines.
The flavonoids and tannins isolated from the methanolic extract from P. nigricans
show considerable antianxiety effect [83]. Pulsatilla nigricans is one of the species
used in traditional medicine for the treatment of nervous exhaustion and anxiety.
Therefore, their high activity permits their application for the treatment of depression.
The confirmation of our results shows the extracts from P. nigricans can also be used
as antifungal agents and to alleviate the weakness of an organism.
Phytochemical studies of the extracts from P. montana subsp. balcana, P. halleri
subsp. rhodopaea, and P. slaviankae have shown polyphenolic compounds, flavonoids,
and anthocyanidins [13]. The highest contents of these substances were established in
the extracts from P. montana subsp. balcana and P. halleri subsp. rhodopaea. The antioxidative properties of P. slaviankae were a consequence of the presence of astragalin,
isoquercetin, quercetin, kaempferol, caffeic acid, and isorhamnetin in the aboveground
shoots of this species [84]. The natural biologically active substances isolated from this
species may play an important role in the protection of humans against breast cancer,
colon cancer, prostate cancer, and leukemia. Phytochemical studies of plant material
from the species P. montana subsp. balcana have also revealed the presence of caffeic
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acid, chlorogenic acid, gallic acid, methylgallic acid, ferulic acid, and ellagic acid [85].
Our results also identified caffeic acid, and so are in some accordance with the observation of these previous studies. The therapeutic effects related to the presence of these
polyphenolic compounds include diastole of blood vessels, and assistance in stabilizing
the blood pressure of patients with heart disease and hypertension.
The chemical composition of extracts from the leaves and roots of P. patens subsp.
patens and P. vulgaris subsp. vulgaris were significantly different. The leaf extracts, in
contrast to the root extracts, contained up to 22% carboxylic acid for P. patens subsp.
patens and 2% for those of P. vulgaris subsp. vulgaris, whereas the leaf extracts showed
lower biological activity. Chemical composition of extracts from dry and raw materials
from this species were slightly different (Łaska and Sienkiewicz, unpublished data), while
the extracts from fresh material were the most rich with compounds. Upon drying,
some compounds were lost through evaporation or destruction.
However, phytochemical analysis of P. patens subsp. patens and P. vulgaris subsp.
vulgaris showed nearly similar results due to the presence of phytochemical constituents.
A previous study on the chemotaxonomic characteristics of Pulsatilla species revealed
that P. patens subsp. patens, P. vulgaris subsp. vulgaris, and P. grandis Wenderoth contain
only delphinidin glycosides, whereas the remaining species [P. halleri subsp. rhodopaea
(Stoj. & Stef.) K. Krause, P. montana subsp. balcana (Vel.) Zamels, P. pratensis (L.)
Mill., P. rubra (Lamk.) Delarbre, and P. vulgaris subsp. vulgaris var. touranginiana E. G.
Camus] contain pelargonidin and delphinidin glycosides [86]. Our studies revealed the
presence of the triterpenoid saponins and the biological activity of the extracts from P.
patens subsp. patens and P. vulgaris subsp. vulgaris. Therefore, isolated saponins have
chemotaxonomic features that may be recognized as specific to Pulsatilla species.
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